Arthur J. Gallagher & Co.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AJG research report →
Range $260 – $300
Price Chart
About the company
Arthur J. Gallagher & Co. , alongside its various subsidiaries, operates globally, providing a wide array of services that encompass insurance brokerage, expert consulting, and outsourced claims settlement and administration.
- CEO
- J. Patrick Gallagher Jr.
- IPO
- 1984
- Employees
- 72,000
- HQ
- Rolling Meadows, IL, US
Get TickerSpark's AI analysis on AJG
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $71.61B
- P/E
- 43.13
- Fwd P/E
- 21.34
- PEG
- 12.53
- P/S
- 4.47
- P/B
- 3.04
- EV/EBITDA
- 17.42
- Div Yield
- 0.96%
- Gross Margin
- 72.89%
- Op Margin
- 17.39%
- Net Margin
- 10.38%
- ROE
- 7.16%
- ROIC
- 5.66%
Latest fiscal year · YoY change
- Revenue
- $13.94B+20.7%
- Gross Profit
- $7.63B+56.5%
- Op Income
- $2.55B
- Net Income
- $1.49B+2.1%
- EPS
- $5.83-12.1%
- OCF Growth
- -25.3%
- FCF Growth
- -26.9%
- 52W High
- $294.53
- 52W Low
- $190.75
- 50D MA
- $254.20
- 200D MA
- $234.28
- Beta
- 0.55
- RSI (14)
- 56
- Avg Volume
- 1.55M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Arthur J. Gallagher posted another strong quarter with 18% total revenue growth in combined Brokerage and Risk Management, 25% net earnings and adjusted EBITDAC growth, and management reaffirmed confidence in another year of solid organic growth and margin expansion.· October 29, 2026
- Combined Brokerage and Risk Management revenue rose 18%, with organic growth of 5%; net earnings and adjusted EBITDAC both increased 25%.
- Brokerage revenue grew 19% with 5% organic growth and a 35.3% adjusted EBITDAC margin, while Risk Management grew 14% with 10% organic growth and a 22.8% margin.
- Management kept its 2026 full-year organic growth outlook at about 6% for combined Brokerage and Risk Management and expects fourth-quarter/full-year brokerage organic growth around 5%.
- AssuredPartners integration is progressing well; AP delivered $285 million of adjusted EBITDAC in the quarter and remains on track for $160 million of annualized run-rate synergies by year-end 2026, rising to $325 million by early 2028.
- Capital deployment remains active: Gallagher completed 5 tuck-in deals in Q3, 21 year-to-date, repurchased about $100 million of stock in the quarter, and said it has more than $12 billion of acquisition capacity over the next 2 years.
Third-quarter combined Brokerage and Risk Management adjusted revenue increased 17%, adjusted EBITDAC increased 25%, and adjusted EPS increased 26%; on a levelized basis excluding the prior-year $76 million of interest income tied to funds held for AssuredPartners, adjusted revenue was up 20%, adjusted EBITDAC up 34%, adjusted EPS up 37%, and adjusted EBITDAC per share up 35%. Net earnings increased 25% and adjusted EBITDAC also increased 25%. Brokerage organic growth was 5% and Risk Management organic growth was 10%. Brokerage adjusted EBITDAC margin was 35.3%, up 200 basis points, and Risk Management adjusted EBITDAC margin was 22.8%, up 90 basis points. Looking ahead, management said fourth-quarter and full-year 2026 brokerage organic growth should be around 5%, combined Brokerage and Risk Management organic growth should be approximately 6% for the full year, and Risk Management margin should be north of 22% in Q4 and full-year 2026. They also said fourth-quarter acquisitions closed through the call could add about $65 million to brokerage revenue and about $5 million to risk management revenue, with fourth-quarter brokerage organic growth including AP expected to carry only a 20 to 25 basis point headwind.
Pat Gallagher’s message was confident and upbeat, centered on the durability of Gallagher’s organic growth engine and the long runway from its diversified model. He emphasized strong retention, new business, exposure growth, and a mix of businesses that can grow across different pricing environments, noting that rates are only about 1 point of organic growth today. He also highlighted macro tailwinds such as infrastructure, energy, data centers, and emerging risks like AI, while reinforcing that the company remains disciplined on M&A and culture.
Doug Howell stressed that results were at or better than what the company outlined at its September Investor Day, calling the quarter “fantastic” and highlighting margin expansion and earnings leverage. He said third-quarter adjusted revenue for the combined segments rose 17% and, after leveling out the prior-year interest income, adjusted revenue was up 20% with adjusted EBITDAC up 34%. He also noted brokerage margin expansion of 60 basis points in the quarter before AP synergies, AP added 310 basis points of margin lift in the quarter, AP delivered $285 million of adjusted EBITDAC, and the company remains on track for $160 million of annualized run-rate synergies by year-end 2026 and $325 million by early 2028. On capital allocation, he said the company repurchased about 400,000 shares for approximately $100 million in Q3, about $580 million through September 30, and estimates more than $12 billion of acquisition capacity over the next 2 years.
Analysts focused on whether 2027 brokerage organic growth assumes the same roughly 1-point rate contribution, and management said yes, it does. They also pressed on AP’s lower organic growth versus legacy Gallagher; management said the gap is mostly a quarter-by-quarter mix issue and that AP is still early in integration, with the expectation that producer productivity should improve as Gallagher tools and capabilities are rolled out. Questions also dug into commission-rate pressure, M&A slowing in the brokerage market, and the short-term delay in benefits consulting projects due to clients prioritizing medical-cost inflation; management said commission rates are steady, M&A remains active but more selective, and the benefits delay looks more like timing than lost demand.
The bullish case from this call is that Gallagher is still producing strong organic growth even as property pricing softens, with management pointing to retention, new business, exposure growth, and cross-selling as the main engines. AP integration is already contributing to margins and earnings, the pipeline remains active, and management sees room for further margin expansion through synergies, technology, and centers of excellence. Management also sounded confident that 2027 can look a lot like 2026 on legacy brokerage and Risk Management, with AP offering additional upside over time.
The main risks discussed were softer property pricing, which is moderating and could continue to weigh on rate-driven growth, and some timing pressure in employee benefits as clients focus on rising medical and prescription costs. Management also acknowledged that brokerage M&A is slowing and that AP currently runs below Gallagher’s organic growth rate, which creates a modest headwind to consolidated organic growth next year. In addition, reinsurance and specialty lines remain competitive and somewhat chunky, so results there can be uneven quarter to quarter.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 98.9%
- Shares Outstanding
- 256.42M
- Float Shares
- 253.63M
of shares held by institutions
1,330 13F filers
Buy/sell ratio 0.38. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for AJG, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Michael McCaulHouse · TX10 | Sell | Aug 25, 26 | Filing → |
| Alan ArmstrongSenate | Buy | Mar 27, 26 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | Jun 3, 26 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | Jun 10, 26 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Jun 2, 26 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | Apr 7, 26 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | Apr 6, 26 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | Mar 12, 26 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | Mar 25, 26 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | Mar 4, 26 | Filing → |
| Gilbert CisnerosHouse · CA31 | Sell | Feb 10, 26 | Filing → |
| Kelly MorrisonHouse · MN03 | Sell | Mar 8, 26 | Filing → |
| Kelly MorrisonHouse · MN03 | Sell | Mar 8, 26 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Jan 13, 26 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 31.39M | ▲ 217.14K |
| Fmr LLC | 21.08M | ▲ 2.43M |
| Blackrock, Inc. | 20.18M | ▲ 356.64K |
| Vanguard Capital Management LLC | 16.78M | ▲ 5.49K |
| Jpmorgan Chase & Co | 13.86M | ▼ 497.60K |
| Capital World Investors | 12.75M | ▲ 233.33K |
| Vanguard Portfolio Management LLC | 12.34M | ▼ 116.59K |
| State Street Corp | 11.34M | ▲ 36.67K |
| Dodge & Cox | 9.48M | ▲ 117.28K |
| Norges Bank | 6.73M | ▲ 6.73M |
| Geode Capital Management, LLC | 6.41M | ▲ 107.46K |
| Eagle Capital Management LLC | 4.26M | ▼ 632.01K |
Held by 1,776 ETFs
Biggest fund positions in AJG by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 16, 26 | HOWELL DOUGLAS K | sell | 5,000 |
| Nov 13, 26 | Pesch Michael Robert | other | 7,520 |
| Nov 13, 26 | Pesch Michael Robert | sell | 7,520 |
| Nov 13, 26 | Pesch Michael Robert | other | 7,520 |
| Nov 9, 26 | Pietrucha Susan E | other | 15,020 |
| Nov 9, 26 | Pietrucha Susan E | sell | 15,020 |
| Nov 9, 26 | Pietrucha Susan E | other | 15,020 |
| Nov 4, 26 | Ziebell William F | other | 23,510 |
| Nov 4, 26 | Ziebell William F | sell | 23,510 |
| Nov 4, 26 | Ziebell William F | other | 23,510 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our AJG coverage
Recent articles, reports, and earnings notes.

Should You Buy Tigerless Health Before the SPAC Merger Closes?
Tigerless Health is a licensed insurance agency focused on health coverage for international students and foreign professionals, and it is going public through a merger with Piermont Valley Acquisition Corp. The deal is still in the shareholder vote and closing process, with Nasdaq tickers expected to be TGAI and TGAIW. The bull case is niche distribution and AI-assisted workflows; the bear case is tiny trust cash, heavy dilution, and a narrow customer base.

Insurance Stocks That Balance Growth and Value: 7 Picks
Seven insurance stocks span life, diversified P&C, personal lines, specialty commercial, and brokerage models, including Allstate, Progressive, Hartford, Cincinnati, and CNO.
Want a deeper read on AJG?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
As Financial Stress Weighs on Workers, Gallagher Introduces a Platform Focused on Better Financial Decision-Making
prnewswire.com · Nov 19
Arthur J. Gallagher & Co. Acquires AgriServ, Inc.
prnewswire.com · Nov 19
Arthur J. Gallagher & Co. (NYSE:AJG) VP Sells $2,122,896.00 in Stock
defenseworld.net · Nov 19
Arthur J. Gallagher & Co. Acquires Bay and Basin Insurance Services, LLC
prnewswire.com · Nov 17
Three in Four Organizations Have Experienced Corporate Crime Incidents as Attacks Grow More Sophisticated, Gallagher Research Finds
prnewswire.com · Nov 16
Arthur J. Gallagher & Co. $AJG Shares Acquired by Eurizon Capital SGR S.p.A.
defenseworld.net · Nov 16
Aberdeen Group plc Buys 172,165 Shares of Arthur J. Gallagher & Co. $AJG
defenseworld.net · Nov 15
BRO's Organic Growth Hinges on New Business and Acquisitions
zacks.com · Nov 13
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.